Clinically apparent hereditary vitamin D-resistant rickets (HVDRR) usually results from a loss of function mutation in the vitamin D receptor (VDR).2 The VDR is a ligand-dependent transcription factor that recognizes and binds to Cisacting vitamin D response elements (VDREs) in the promoter regions of target genes to induce or repress transcription. In addition to VDR, there are many other factors that act to "fine tune" hormone responsiveness. First among these is the circulating vitamin D-binding protein that delivers active vitamin D metabolites to target tissues (1, 2). Second are the various "acceptor" proteins, such as megalin and cubulin (3-6), which are anchored in the plasma membrane of target cells and promote internalization of steroid hormones. Third are the so-called "co-integrator" chaperone proteins that direct the intracellular trafficking of vitamin D metabolites for metabolism, catabolism, and transactivation via the VDR (7,8). Fourth is the cognate VDR dimerization partner retinoid X receptor (RXR) (9, 10). Fifth are receptor-associated coactivators and co-repressors that influence recruitment of other elements of the transcriptional machinery to the promoter (11, 12). And sixth are the "co-modulator" Cis-acting proteins of the heterogeneous nuclear ribonucleoprotein (hnRNP) family that compete with the VDR-RXR for binding to the vitamin D response element (VDRE), thus altering hormone receptor-directed transactivation (13-15). The hnRNPs, first recognized for their ability to bind single strand ribopolynucleotides (16,17), are a family of more than 20 proteins that contribute to the complex associated with nascent pre-mRNA and are thus able to modulate RNA processing, including the stabilization of pre-mRNAs for nuclear export and translation (18 -20). More recently, hnRNPs have been shown to be capable of binding DNA in both single-(16, 17) and double-stranded formats (14,15). Acting in their capacity as double-stranded DNA-binding proteins, we have shown previously that individual hnRNPs may function as dominant-negative modulators of steroid hormone-mediated transcription by competing with the VDR-RXR (14, 15) and the estrogen receptor (21-23) for VDRE and estrogen response element, respectively. Here we describe the isolation, purification, and cloning of the cDNA for the naturally occurring human retinoid X and vitamin D response element-binding protein (REBiP), which was shown to be hnRNP C1/C2. In further studies, we have demonstrated the ability of the REBiP to exert a dominantnegative effect on 1,25-dihydroxy vitamin D 3 (1,25(OH) 2 D 3 )-induced transcription via the naturally occurring VDRE in the